A Multicener, Randomised, Double-blind, Placebo-controlled Study, to Assess the Long Term Safety of 52 Weeks Treatment With QVA149 (110 ug Indacaterol/50ug Glycopyrrolate) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
A Multicener, Randomised, Double-blind, Placebo-controlled Study, to Assess the Long Term Safety of 52 Weeks Treatment With QVA149 (110 ug Indacaterol/50ug Glycopyrrolate) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
The study is designed to provide long-term safety data for QVA149 in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Inclusion Criteria:
Exclusion Criteria:
Ferolles-Attily, France 77150, France
Chennai - Tamil Nadu, India 600 087, India
Banglaore, Karnataka 560027, India
Koyang-si, Gyeonggi-do 410-773, South Korea
Lancashire, FY3 7EN, United Kingdom